For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
a company based in Los Angeles, California, landed FDA clearance for the first device to actually objectively evaluate a patient’s proclivity for developing a pressure ulcer in a given part of the body. The SEM Scanner wireless handheld device is intended to be used as an adjunct to the standard of care when evaluating patients at an increased risk of getting pressure ulcers.
It detects changes in the sub-epidermal moisture, which can indicate localized edema and tissue fluid related inflammation days before visually discernible skin damage.
“Having anatomically specific risk information gives nurses valuable advance notice to institute additional preventive treatment tailored to a patient’s unique needs,” in a statement said Dr. Ruth Bryant, a SEM Scanner study investigator, author of “Acute & Chronic Wounds” (2016), certified wound ostomy continence nurse, director of nursing research at Abbott Northwestern Hospital in Minneapolis and president-elect of the Association for the Advancement of Wound Care.